Association between the dopamine transporter gene and posttraumatic stress disorder

Molecular Psychiatry

Volumn 7, Issue 8, 2002, Pages 903-907

  Segman, R H ^a   Cooper Kazaz, R ^a   Macciardi, F ^b   Goltser, T ^a   Halfon, Y ^a   Dobroborski, T ^a   Shalev, A Y ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Dopamine transporter; Genetic association; Posttraumatic stress disorder

Indexed keywords

DOPAMINE TRANSPORTER;

ADULT; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC TRANSMISSION; FEMALE; GENETIC ASSOCIATION; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; SOLDIER; TWINS; VARIABLE NUMBER OF TANDEM REPEAT; VIET NAM;

ADULT; BRAIN CHEMISTRY; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MIDDLE AGED; NERVE TISSUE PROTEINS; STRESS DISORDERS, POST-TRAUMATIC;

EID: 0036385710     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mp.4001085     Document Type: Article

References (31)

1. True WR, Rice J, Eisen SA, Heath AC, Goldberg J, Lyons MJ, Nowak J. A twin study of genetic and environmental contributions to liability for posttraumatic stress symptoms. Arch Gen Psychiatry 1993; 50: 257-264.
2. Xian H, Chantarujikapong SI, Scherrer JF, Eisen SA, Lyons MJ, Goldberg J et al. Genetic and environmental influences on PTSD, alcohol and drug dependence in twin pairs. Drug Alc Depend 2000; 61: 95-102.
3. Brewin CR, Andrews B, Valentine JD. Meta analysis of risk factors for posttraumatic stress disorder. J Consult Clin Psychol 2000; 68: 784-766.
4. Yehuda R, McFarlane AC. Conflict between current knowledge about posttraumatic stress disorder and its original conceptual basis. Am J Psychiatry 1995; 152: 1705-1713.
5. Shalev AY, Pitman RK, Orr SP, Peri T, Brandes D. Auditory startle in trauma survivors with PTSD: a prospective study. Am J Psychiatry 2000; 157: 255-261.
6. Connor KM, Davidson JRT. Familial risk factors in PTSD. Ann NY Acad Sci 1997; 821: 35-51.
7. Comings DE, Muhleman D, Gysin R. Dopamine D2 receptor (DRD2) gene and susceptibility to posttraumatic stress disorder: a study and replication. Biol Psychiatry 1996; 40: 368-372.
8. Gelernter J, Southwick S, Goodson S, Morgan A, Nagy L, Charney DS. No association between D2 dopamine receptor (DRD2) 'A' system alleles, or DRD2 haplotypes, and posttraumatic stress disorder. Biol Psychiatry 1999; 45: 620-625.
9. Yehuda R, Southwick S, Giller EL, Ma X, Mason JW. Urinary catecholamine excretion and severity of PTSD symptoms in Vietnam combat veterans. J Nerv Ment Dis 1992; 180: 321-325.
10. Lemieux AM, Coe CL. Abuse related PTSD: evidence for chronic neuroendocrine activation in women. Psychosom Med 1995; 57: 105-115.
11. Spivak B, Vered Y, Graff E, Blum I, Mester R, Weizman A. Low platelet-poor plasma concentrations of serotonin in patients with combat related PTSD. Biol Psychiatry 1999; 45: 840-845.
12. De Bellis MD, Baum AS, Birmaher B, Keshavan MS, Eccard CH, Boring AM et al. Bennett Research Award. Developmental traumatology. Part I: Biological stress systems. Biol Psychiatry 1999; 45: 1259-1270.
13. Hamner MB, Diamond BI. Elevated plasma dopamine in posttraumatic stress disorder: a preliminary report. Biol Psychiatry 1993; 33: 304-306.
14. Inglis FM, Moghaddam B. Dopaminergic innervation of the amygdala is highly responsive to stress. J Neurochem 1999; 72: 1088-1094.
15. Goldstien LE, Rasmussen AM, Bunney BS, Roth RH. Role of the amygdala in the coordination of behavioral neuroendocrine and prefrontal cortical monoamine responses to psychological stress in the rat. J Neurosci 1996; 16: 4787-4798.
16. Puglisi-Allegra S, Cabib S. Psychopharmacology of dopamine: The contribution of comparative studies in inbred strains of mice. Prog Neurobiol 1997; 51: 637-661.
17. Cabib S, Oliverio A, Ventura R, Lucchese F, Puglisi-Allegra S. Brain dopamine receptor plasticity: testing a diathesis-stress hypothesis in an animal model. Psychopharmacology 1997; 132: 153-160.
18. Post RM, Weiss SRB, Li H, Leverich GS, Pert A. Sensitization components of PTSD: implications for therapeutics. Semin Clin Neuropsychiatry 1999; 4: 282-294.
19. Vandenbergh DJ, Persico AM, Hawkins AL, Griffin CA, Li X, Jabs EW, Uhl GR. Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR. Genomics 1992; 14: 1104-1106.
20. Cook EH, Stein MA, Krasowski MD, Cox NJ, Olkon DM, Kieffer JE, Leventhal BL. Association of attention-deficit disorder and the dopamine transporter gene. Am J Hum Genet 1995; 56: 993-998.
21. Sabol SZ, Nelson ML, Fisher C, Gunzerath L, Brody CL, Hu S et al. A genetic association for cigarette smoking behavior. Health Psychol 1999; 18: 7-13.
22. Jacobsen LK, Staley JK, Zoghbi SS, Seibyl JP, Kosten TR, Innis RB, Gelernter J. Prediction of dopamine transporter binding availability by genotype: a preliminary report. Am J Psychiatry 2000; 157: 1700-1703.
23. Heinz A, Goldman D, Jones DW, Palmour R, Hemmer D, Gorey JG et al. Genotype influences in vivo dopamine availability in human striatum. Neuropsychopharmacology 2000; 22: 133-139.
24. Freedman SA, Peri T, Brandes D, Shalev AY. Predictors of chronic PTSD: a prospective study. Br J Psychiatry 1999; 174: 353-359.
25. Mander A, Clayton D. Haplotype analysis in population-based association studies using Stata. Stata Techn Bull 2000; 57: 5-7.
26. Kessler RC, Sonega A, Bromet E, Hughes M, Nelson CB. Posttraumatic stress disorder in the national comorbidity survey. Arch Gen Psychiatry 1995; 52: 1048-1060.
27. Frisch A, Postilnick D, Rockah R, Michaelovsky E, Postilnick S, Birman E et al. Association of unipolar major depressive disorder with genes of the serotonergic and dopaminergic pathways. Mol Psychiatry 1999; 4: 389-392.
28. Kang AM, Palmatier MA, Kidd KK. Global variation of a 40-bp VNTR in the 3′ untranslated region of the dopamine transporter gene (SLC6A3). Biol Psychiatry 1999; 46: 151-160.
29. Blake DD, Weathers FW, Nagy LM, Kaloupek DG, Klaminzer G, Charney DS, Keane TM. A clinician rating scale for assessing current and life time PTSD. The CAPS-I. Behavior Therapist 1990; 13: 187-188.
30. Spitzer RL, Williams JBW, Gibbon M. Structured Clinical Interview for DSM-III-R (SCID). New York State Psychiatric Institute, Biometrics Research: New York, 1987.
31. Lerer B, Macciardi F, Segman RH, Adolfsson R, Blackwood D, Blairy S et al. Variability of 5-HT2C receptor cys23ser polymorphism among European populations and vulnerability to affective disorder. Mol Psychiatry 2001; 5: 579-585.